Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
ATOS US​

Atossa Therapeutics, Inc.(ATOS US)

$2.60-0.124.41%Ext:$2.58-0.020.77%(Market Closed · 23:51:54 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

Financials(63)

Expand
  • 10-QQ2ended 30 Jun 20267 Aug
  • 10-QQ1ended 31 Mar 20268 May
  • 10-KFY 2025ended 31 Dec 202525 Mar
  • 10-QQ3ended 30 Sept 202512 Nov 2025
  • 10-QQ2ended 30 Jun 202512 Aug 2025
  • 10-QQ1ended 31 Mar 202513 May 2025
  • 10-KFY 2024ended 31 Dec 202425 Mar 2025
  • 10-QQ3ended 30 Sept 202412 Nov 2024
  • 10-QQ2ended 30 Jun 202412 Aug 2024
  • 10-QQ1ended 31 Mar 202413 May 2024
  • 10-KFY 2023ended 31 Dec 20231 Apr 2024
  • 10-QQ3ended 30 Sept 202313 Nov 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023
  • 10-QQ1ended 31 Mar 202315 May 2023
  • 10-KFY 2022ended 31 Dec 202222 Mar 2023

Events(177)

Expand
  • 8-KEntry into a Material Definitive Agreement9 Oct
  • 8-KOther Events29 Sep
  • 8-KRegulation FD Disclosure18 Sep
  • 8-KResults of Operations and Financial Condition7 Aug
  • 8-KEntry into a Material Definitive Agreement11 Jun
  • 8-KFinancial Statements and Exhibits8 May
  • 8-KSubmission of Matters to a Vote of Security Holders8 May
  • 8-KOther Events16 Apr
  • 8-KFinancial Statements and Exhibits25 Mar
  • 8-KEntry into a Material Definitive Agreement20 Feb
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing17 Feb
  • 8-KRegulation FD Disclosure11 Feb
  • 8-KMaterial Modifications to Rights of Security Holders26 Jan
  • 8-KResults of Operations and Financial Condition9 Jan
  • 8-KOther Events6 Jan

Insider Ownership(161)

Expand
  • 4Statement of changes in beneficial ownership14 May
  • 4Statement of changes in beneficial ownership14 May
  • 4Statement of changes in beneficial ownership14 May
  • 4Statement of changes in beneficial ownership14 May
  • 4Statement of changes in beneficial ownership14 May
  • 4Statement of changes in beneficial ownership14 May
  • 4Statement of changes in beneficial ownership31 Mar
  • 4Statement of changes in beneficial ownership30 Mar
  • 4/AStatement of changes in beneficial ownership (amendment)30 Jan
  • 4Statement of changes in beneficial ownership22 Jan
  • 3Initial statement of beneficial ownership21 Oct 2025
  • 4Statement of changes in beneficial ownership21 Oct 2025
  • 4Statement of changes in beneficial ownership22 May 2025
  • 4Statement of changes in beneficial ownership16 May 2025
  • 4Statement of changes in beneficial ownership16 May 2025

Beneficial Ownership(29)

Expand
  • SC 13G/AATOSSA THERAPEUTICS, INC.29 Jul 2025
  • SC 13G/AATOSSA THERAPEUTICS, INC.16 Jul 2025
  • SC 13G/AATOSSA THERAPEUTICS, INC.7 Feb 2025
  • SC 13G/AATOSSA THERAPEUTICS, INC.12 Nov 2024
  • SC 13GATOSSA THERAPEUTICS, INC.8 Nov 2024
  • SC 13G/AATOSSA THERAPEUTICS, INC.4 Nov 2024
  • SC 13GATOSSA THERAPEUTICS, INC.22 Oct 2024
  • SC 13G/AATOSSA THERAPEUTICS, INC.9 Feb 2023
  • SC 13GATOSSA THERAPEUTICS, INC.8 Jul 2022
  • SC 13G/AATOSSA THERAPEUTICS, INC.14 Feb 2022
  • SC 13GATOSSA THERAPEUTICS, INC.9 Feb 2022
  • SC 13GATOSSA THERAPEUTICS, INC.4 Feb 2022
  • SC 13G/AATOSSA THERAPEUTICS, INC.13 Jan 2022
  • SC 13GATOSSA THERAPEUTICS, INC.15 Jan 2021
  • SC 13GATOSSA THERAPEUTICS, INC.15 Jan 2021

Proxies(33)

Expand
  • ARSAnnual report to security holders30 Mar
  • DEF 14ADefinitive proxy statement30 Mar
  • PRE 14APreliminary proxy statement20 Mar
  • DEF 14ADefinitive proxy statement22 Dec 2025
  • PRE 14APreliminary proxy statement12 Dec 2025
  • DEF 14ADefinitive proxy statement26 Mar 2025
  • ARSAnnual report to security holders26 Mar 2025
  • DEF 14ADefinitive proxy statement23 May 2024
  • ARSAnnual report to security holders10 May 2024
  • PRE 14APreliminary proxy statement10 May 2024
  • DEFA14ADefinitive additional materials26 Apr 2023
  • DEF 14ADefinitive proxy statement30 Mar 2023
  • ARSAnnual report to security holders30 Mar 2023
  • DEF 14ADefinitive proxy statement11 Apr 2022
  • PRE 14APreliminary proxy statement1 Apr 2022

Registrations(92)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))12 Jun
  • 424B5Prospectus filing (Rule 424(b)(5))20 Feb
  • 424B3Prospectus filing (Rule 424(b)(3))20 Feb
  • S-8Registration statement (employee benefit plan)26 Mar 2025
  • 424B5Prospectus filing (Rule 424(b)(5))19 Nov 2024
  • DEL AMDelisting application14 May 2024
  • S-3Registration statement (primary offering)13 May 2024
  • S-3Registration statement (primary offering)21 Apr 2021
  • S-8Registration statement (employee benefit plan)31 Mar 2021
  • 424B5Prospectus filing (Rule 424(b)(5))23 Mar 2021
  • S-3MEFRegistration statement (additional securities, S-3)22 Mar 2021
  • 424B2Prospectus filing (Rule 424(b)(2))4 Feb 2021
  • S-3Registration statement (primary offering)22 Jan 2021
  • 424B3Prospectus filing (Rule 424(b)(3))8 Jan 2021
  • 424B5Prospectus filing (Rule 424(b)(5))21 Dec 2020

Filing Review Correspondence(39)

Expand
  • CORRESPFiling review correspondence21 May 2024
  • CORRESPFiling review correspondence27 Apr 2021
  • CORRESPFiling review correspondence28 Jan 2021
  • CORRESPFiling review correspondence7 Dec 2020
  • CORRESPFiling review correspondence7 Dec 2020
  • CORRESPFiling review correspondence8 Sep 2020
  • CORRESPFiling review correspondence12 Jun 2018
  • CORRESPFiling review correspondence7 May 2018
  • CORRESPFiling review correspondence7 May 2018
  • CORRESPFiling review correspondence3 May 2018
  • CORRESPFiling review correspondence23 Apr 2018
  • CORRESPFiling review correspondence3 Oct 2017
  • CORRESPFiling review correspondence28 Mar 2017
  • CORRESPFiling review correspondence28 Mar 2017
  • CORRESPFiling review correspondence23 Mar 2017

SEC Orders And Notices(21)

Expand
  • EFFECTNotice of effectiveness23 May 2024
  • EFFECTNotice of effectiveness29 Apr 2021
  • EFFECTNotice of effectiveness29 Jan 2021
  • EFFECTNotice of effectiveness8 Dec 2020
  • EFFECTNotice of effectiveness10 Sep 2020
  • EFFECTNotice of effectiveness14 Jun 2018
  • EFFECTNotice of effectiveness9 May 2018
  • EFFECTNotice of effectiveness5 Oct 2017
  • EFFECTNotice of effectiveness28 Mar 2017
  • EFFECTNotice of effectiveness15 Jun 2016
  • EFFECTNotice of effectiveness16 Dec 2015
  • EFFECTNotice of effectiveness8 Jul 2015
  • EFFECTNotice of effectiveness8 May 2015
  • EFFECTNotice of effectiveness25 Apr 2014
  • EFFECTNotice of effectiveness21 Apr 2014

Exempt Offerings(5)

Expand
  • DNotice of exempt offering of securities (Reg D)11 Apr 2013
  • D/ANotice of exempt offering of securities (Reg D, amendment)24 Jun 2011
  • DNotice of exempt offering of securities (Reg D)13 May 2011
  • D/ANotice of exempt offering of securities (Reg D, amendment)28 Sep 2010
  • DNotice of exempt offering of securities (Reg D)24 Jun 2010

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT7 Nov 2012